| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022616 |
| Receipt No. | R000026067 |
| Official scientific title of the study | Relationship Between Sleep Apnea and Fatty Acid Profiles in Patients Who Underwent Percutaneous Coronary Intervention |
| Date of disclosure of the study information | 2016/06/06 |
| Last modified on | 2016/06/07 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Relationship Between Sleep Apnea and Fatty Acid Profiles in Patients Who Underwent Percutaneous Coronary Intervention | |
| Title of the study (Brief title) | Relationship Between Sleep Apnea and Fatty Acid Profiles in Patients Who Underwent Percutaneous Coronary Intervention | |
| Region |
|
|
| Condition | ||||
| Condition | Sleep apnea syndrome | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To clarify whether the presence and also the severity of sleep apnea in dyslipidemia patients who underwent percutaneous coronary intervention affects the fatty acids profiles. |
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Nocturnal oxygen desaturation index and fatty acids concentration |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who were performed PCI and screened SpO2 by nocturnal pulseoximeter | |||
| Key exclusion criteria | Patients who meet the following conditions.
1. Patients who requires oxygen support 2. Patients who received EPA treatment on admission |
|||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Kentaro Jujo |
| Organization | Tokyo Women's Medical University |
| Division name | Department of Cardiology |
| Address | 8-1, Kawada-cho, Shinjuku-ku, Tokyo, Japan |
| TEL | +81333538111 |
| juken1123@hotmail.co.jp | |
| Public contact | |
| Name of contact person | Kentaro Jujo |
| Organization | Tokyo women's Medical Hospital |
| Division name | Cardiology |
| Address | 8-1, Kawada-cho, Shinjuku-ku, Tokyo, Japan |
| TEL | +81333538111 |
| Homepage URL | |
| juken1123@hotmail.co.jp | |
| Sponsor | |
| Institute | Tokyo women's Medical Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Tokyo women's Medical Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Prospectively enrollment
Retrospectively analysis |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026067 |